摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Nα-Fmoc-Lys-OBzl | 236404-46-9

中文名称
——
中文别名
——
英文名称
Nα-Fmoc-Lys-OBzl
英文别名
benzyl (((9H-fluoren-9-yl)methoxy)carbonyl)-L-lysine;(S)-benzyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-6-aminohexanoate;Fmoc-Lys-OBn;benzyl (2S)-6-amino-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoate
N<sup>α</sup>-Fmoc-Lys-OBzl化学式
CAS
236404-46-9
化学式
C28H30N2O4
mdl
——
分子量
458.557
InChiKey
IQQOKQGJGVWWAQ-SANMLTNESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    34
  • 可旋转键数:
    12
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    90.6
  • 氢给体数:
    2
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Non-proteinogenic amino acids in the pThr-2 position of a pentamer peptide that confer high binding affinity for the polo box domain (PBD) of polo-like kinase 1 (Plk1)
    摘要:
    We report herein that incorporating long-chain alkylphenyl-containing non-proteinogenic amino acids in place of His at the pT-2 position of the parent polo-like kinase 1 (Plk1) polo box domain (PBD)-binding pentapeptide, PLHSpT (1a) increases affinity. For certain analogs, approximately two orders-of-magnitude improvement in affinity was observed. Although, none of the new analogs was as potent as our previously described peptide 1b, in which the pT-2 histidine imidazole ring is alkylated at its pi nitrogen (N3), our current finding that the isomeric His(N1)-analog (1c) binds with approximately 50-fold less affinity than 1b, indicates the positional importance of attachment to the His imidazole ring. Our demonstration that a range of modified residues at the pT-2 position can enhance binding affinity, should facilitate the development of minimally-sized Plk1 PBD-binding antagonists. Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2012.10.093
  • 作为产物:
    描述:
    Fmoc-Lys(Boc)-OBn三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 生成 Nα-Fmoc-Lys-OBzl
    参考文献:
    名称:
    用于癌症免疫治疗的蛋白酪氨酸磷酸酶 1B 和 T 细胞蛋白酪氨酸磷酸酶的小分子降解剂
    摘要:
    发现了蛋白酪氨酸磷酸酶 1B (PTP1B) 和 T 细胞蛋白酪氨酸磷酸酶 (TC-PTP) 抑制剂,并将其转化为针对这两个靶标的一流、有效、选择性的双 PROTAC 降解剂。该降解剂促进肿瘤细胞的抗原呈递并激活 CD8+ T 细胞。重要的是,该降解剂在体内有效并抑制同基因肿瘤生长。
    DOI:
    10.1002/anie.202303818
点击查看最新优质反应信息

文献信息

  • NOVEL MULTIMERIC MOLECULES, A PROCESS FOR PREPARING THE SAME AND THE USE THEREOF FOR MANUFACTURING MEDICINAL DRUGS
    申请人:Guichard Gilles
    公开号:US20100136034A1
    公开(公告)日:2010-06-03
    The invention relates to a compound of the formula (I): in which k and j are independently 0 or 1, Y is a macrocycle in which the cycle includes 9 to 36 carbon atoms and is functionalised by three amino functions and by a chain for attaching the spacer arm Z via an X bond, R c is a binding pattern with a receptor of the TNF superfamily, X is a chemical function for binding the Y group to the space arm, and Z is a bi-, tri- or tetra-functional spacer arm.
    该发明涉及以下式(I)的化合物: 其中k和j独立地为0或1,Y是一个大环,其中该环包括9至36个碳原子,并且通过三个基功能和通过链将间隔臂Z通过X键连接的功能化,Rc是与TNF超家族受体的结合模式,X是用于将Y基固定到空间臂的化学功能,Z是双功能、三功能或四功能间隔臂。
  • Peptides for Treatment of Obesity
    申请人:Conde-Frieboes Kilian Waldemar
    公开号:US20130012432A1
    公开(公告)日:2013-01-10
    The present invention relates to novel peptide compounds which are effective in modulating one or more melanocortin receptor types, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of obesity as well as a variety of diseases or conditions associated with obesity.
    本发明涉及一种新型肽化合物,其有效调节一个或多个黑色素皮质素受体类型,以及该类化合物在治疗中的应用,包括通过将该类化合物用于需要的患者进行治疗的方法,以及该类化合物在制造药物中的应用。本发明的化合物在治疗肥胖以及与肥胖相关的各种疾病或症状方面具有特别的兴趣。
  • [EN] STEROID CONJUGATE<br/>[FR] CONJUGUÉ DE STÉROÏDES<br/>[ZH] 一种甾体偶联物
    申请人:[en]DUALITY BIOLOGICS (SUZHOU) CO., LTD.;[zh]映恩生物制药(苏州)有限公司
    公开号:WO2022171101A1
    公开(公告)日:2022-08-18
    涉及一种甾体偶联物,具体涉及化合物或其互变异构体、内消旋体、外消旋体、对映异构体、非对映异构体、或其混合物形式,或其可药用的盐。还涉及本申请化合物的制备方法及其应用。
  • Synthesis and antibacterial activity of amphiphilic lysine-ligated neomycin B conjugates
    作者:Smritilekha Bera、George G. Zhanel、Frank Schweizer
    DOI:10.1016/j.carres.2011.01.015
    日期:2011.4
    Amphiphilic lysine-ligated neomycin B building blocks were prepared by reductive amination of a protected C5 ''-modified neomycin B-based aldehyde and side chain-unprotected lysine or lysine-containing peptides. It was demonstrated that a suitably protected lysine-ligated neomycin B conjugate (NeoK) serves as a building block for peptide synthesis, enabling incorporation of aminoglycoside binding sites into peptides. Antibacterial testing of three amphiphilic lysine-ligated neomycin B conjugates against a representative panel of Gram-positive and Gram-negative strains demonstrates that C5 ''-modified neomycin-lysine conjugate retains antibacterial activity. However, in most cases the lysine-ligated neomycin B analogs display reduced potency against Gram-positive strains when compared to unmodified neomycin B or unligated peptide. An exception is MRSA where an eightfold enhancement was observed. When compared to unmodified neomycin B, the prepared lysine-neomycin conjugates exhibited a 4-8-fold enhanced Gram-negative activity against Pseudomonas aeruginosa and up to 12-fold enhanced activity was observed when compared to unligated reference peptides. (C) 2011 Elsevier Ltd. All rights reserved.
  • Matsoukas; Hondrelis; Agelis, Journal of Medicinal Chemistry, 1994, vol. 37, # 18, p. 2958 - 2969
    作者:Matsoukas、Hondrelis、Agelis、Barlos、Gatos、Ganter、Moore、Moore
    DOI:——
    日期:——
查看更多

同类化合物

(S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 黎芦碱 鳥胺酸 魏因勒卜链接剂 雷迪帕韦二丙酮合物 雷迪帕韦中间体6 雷迪帕韦 雷迪帕维中间体 雷迪帕维中间体 雷尼托林 锰(2+)二{[乙酰基(9H-芴-2-基)氨基]氧烷负离子} 醋酸丁酸纤维素 达托霉素杂质 赖氨酸杂质4 试剂9,9-Dioctyl-9H-fluoren-2-amine 螺[环戊烷-1,9'-芴] 螺[环庚烷-1,9'-芴] 螺[环己烷-1,9'-芴] 螺[3.3]庚烷-2,6-二-(2',2'',7',7''-四碘螺芴) 螺-(金刚烷-2,9'-芴) 螺(环己烷-1,9'-芴)-3-酮 藜芦托素 荧蒽 反式-2,3-二氢二醇 草甘膦-FMOC 英地卡胺 苯芴醇杂质A 苯甲酸-(芴-9-基-苯基-甲基酯) 苯甲酸-(9-苯基-芴-9-基酯) 苯并[b]芴铯盐 苯并[a]芴酮 苯基芴胺 苯基(9-苯基-9-芴基)甲醇 苯(甲)醛,9H-芴-9-亚基腙 苯(甲)醛,4-羟基-3-甲氧基-,(3-甲基-9H-茚并[2,1-c]吡啶-9-亚基)腙 芴甲氧羰酰胺 芴甲氧羰酰基高苯丙氨酸 芴甲氧羰酰基肌氨酸 芴甲氧羰酰基环己基甘氨酸 芴甲氧羰酰基正亮氨酸 芴甲氧羰酰基D-环己基甘氨酸 芴甲氧羰酰基D-Β环己基丙氨酸 芴甲氧羰酰基-O-三苯甲基丝氨酸 芴甲氧羰酰基-D-正亮氨酸 芴甲氧羰酰基-6-氨基己酸 芴甲氧羰基-高丝氨酸内酯 芴甲氧羰基-缬氨酸-1-13C 芴甲氧羰基-叔丁基二甲基硅-D-丝氨酸 芴甲氧羰基-beta-赖氨酰酸(叔丁氧羰基) 芴甲氧羰基-S-叔丁基-L-半胱氨酸五氟苯基脂